Liver transplantation is associated with a number of neurological complications. We herein report a case of chronic inflammatory demyelinating polyneuropathy associated with the use of sirolimus-based immunosuppression. The patient was treated by converting the immunosuppression from sirolimus to cyclosporine and by a short course of oral steroids. Following this, we observed almost complete clinical and electrophysiologic resolution of this syndrome. We believe that this is the first described case of such a complication occurring in association with sirolimus. This immunosuppressive agent can, therefore, lead to neurological complications similar to the ones that have been observed with calcineurin inhibitors
Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to m...
The use of sirolimus as an alternative to calcineurin antagonists has enabled the continuation of im...
Brock Macdonald1, Evi Vakiani2, Rhonda K Yantiss3, Jun Lee4, Robert S Brown Jr5, Samuel H Sigal61Div...
Patients, in particular recipients of orthotopic liver transplants, receiving the immunosuppressant ...
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyel...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyel...
Abstract Introduction Neurological complications leading to morbidity and mortality are not frequent...
Neurological complications are common after liver transplantation, as they affect up to one-third of...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Sirolimus, a potent inhibitor of B- and T-cell activation. is a commonly used immunosuppressant afte...
Sirolimus (SRL) is a newer immunosuppressant whose possible benefits and side effects in comparison ...
Sirolimus is a potent immunosuppressant with a mechanism of action different from calcineurin inhibi...
Sirolimus (SRL) is a newer immunosuppressant whose possible benefits and side effects in comparison ...
Neurologic complications are common after solid organ transplantation and are associated with signif...
Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to m...
The use of sirolimus as an alternative to calcineurin antagonists has enabled the continuation of im...
Brock Macdonald1, Evi Vakiani2, Rhonda K Yantiss3, Jun Lee4, Robert S Brown Jr5, Samuel H Sigal61Div...
Patients, in particular recipients of orthotopic liver transplants, receiving the immunosuppressant ...
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyel...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyel...
Abstract Introduction Neurological complications leading to morbidity and mortality are not frequent...
Neurological complications are common after liver transplantation, as they affect up to one-third of...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Sirolimus, a potent inhibitor of B- and T-cell activation. is a commonly used immunosuppressant afte...
Sirolimus (SRL) is a newer immunosuppressant whose possible benefits and side effects in comparison ...
Sirolimus is a potent immunosuppressant with a mechanism of action different from calcineurin inhibi...
Sirolimus (SRL) is a newer immunosuppressant whose possible benefits and side effects in comparison ...
Neurologic complications are common after solid organ transplantation and are associated with signif...
Leukoencephalopathy is a structural alteration of cerebral white matter mainly involving damage to m...
The use of sirolimus as an alternative to calcineurin antagonists has enabled the continuation of im...
Brock Macdonald1, Evi Vakiani2, Rhonda K Yantiss3, Jun Lee4, Robert S Brown Jr5, Samuel H Sigal61Div...